NCCN Guidelines for Patients® | Chronic Myelogenous Leukemia - page 27

NCCN Guidelines for Patients
: Chronic Myelogenous Leukemia
Version 1.2014
Par t 7
Par t 6
Par t 5
Par t 4
Par t 3
Par t 2
Par t 1
Part 4: Overview of cancer treatments
4.1 – Tyrosine kinase inhibitor therapy
Describes the use of drugs that specifically
target chronic myelogenous leukemia cells.
4.2 – Immunotherapy
Describes the use of drugs that boost the
body’s natural defense against infection and
disease—immune system—to fight cancer cells.
4.3 – Chemotherapy
Describes the use of drugs that kill rapidly dividing
cells to treat chronic myelogenous leukemia.
4.4 – Stem cell transplant and donor
lymphocyte infusion
Describes a treatment that replaces damaged
bone marrow with healthy stem cells and a
treatment that gives you more white blood cells
to help your body fight the cancer.
4.5 – Clinical trials
Describes a type of research that may be a
treatment option.
4.6 – Tools
Lists helpful webpages as well as questions
about treatment to ask your doctor.
There is more than one treatment for chronic
myelogenous leukemia. Which treatment you will
receive depends on many factors such as your age,
general health, and the cancer phase. The main types
of treatments for chronic myelogenous leukemia are
described on the next pages. This information may
help you better understand your treatment options and
use the treatment guide in Part 5. It may also help you
know what to expect during treatment. Not every person
with chronic myelogenous leukemia will receive every
treatment listed.
1...,17,18,19,20,21,22,23,24,25,26 28,29,30,31,32,33,34,35,36,37,...100
Powered by FlippingBook